Meet the team
The Syntactx Team is comprised of passionate, knowledgeable, and experienced individuals with deep roots in various facets of healthcare. Our dedication to medical research and aligned goals provide our clients with a professional experience that will address their unique challenges.
Kenneth Ouriel, MD, MBAPresident & CEO
David Ouriel, MBA, CFAChief Operating Officer
Richard OurielVice President, Core Laboratory
Stefaan Van der MeulenManaging Director, Syntactx EU
Mark Adelman, MDChief Medical Officer
David Snead, PhDSenior Principal Biostatistician
Corie Diaz, MBAAssociate Director of Clinical Operations
Joanna Adrian, MBADirector of Operations
Darlene GarnerManager, Regulatory Affairs
Debbie Mange, RNSenior Clinical Program Manager
Gijs Klarenbeek, MDSenior Medical Director
Tineke Scheers, PhDClinical Research Professional
Paulo AlegreInformation Technology Director
Keith Witek, MBAHuman Resources Manager
Key Opinion Leader Network
From idea conception to entry into the marketplace, guidance from key opinion leaders is crucial.
Depending on a client’s needs, Syntactx leverages and engages long-standing relationships with clinicians and institutions from a wide array of specialties and experiences to assist in activities including Trial Design and Development, Clinical Events Committees, Data Safety Monitoring Boards, and physician review of Core Laboratory Imaging.
Clinical Research Associates (CRAs)
Syntactx CRAs possess a broad range of experience and expertise to seamlessly facilitate and streamline study execution.
Our CRAs are highly trained and able to assist with a multitude of issues, both routine and complex - from assisting with the creation of study-specific case report forms, to safety surveillance and data analysis; no aspect of study site coordination is beyond our abilities.
In addition to data verification and site monitoring, our CRAs build effective relationships with study Sponsors and site staff, perform site and project management, and monitor enrollment activities in an effort to expedite the path to approval. In an environment of ever-increasing regulation and increasing timelines, Syntactx CRAs work hard to ensure timely and accurate results.